Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat-Reference-Cited by-同舟云学术

Feline restrictive orbital myofibroblastic sarcoma treated with toceranib phosphate (Palladia) as adjuvant chemotherapy: A case study of one cat

Published:2023-06 Issue:6 Volume:11 Page:
ISSN:2050-0904
Container-title:Clinical Case Reports
language:en
Short-container-title:Clinical Case Reports

Author:

Komatsu Hiroyuki¹^ORCID,Ueshima Asuka²,Kobayashi Yoshitaka¹²^ORCID,Shimoyama Yumiko³,Takiyama Naoaki⁴,Rimpo Kenji²

Affiliation:

1. Animal Eye Care‐Tokyo Animal Eye Clinic Tokyo Japan

2. Saitama Animal Medical Center Saitama Japan

3. IDEXX Laboratories Tokyo Japan

4. Veterinary Eye Clinic Nagoya Nagoya Japan

Abstract

Key Clinical MessageThis is the first case report of treatment with toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS. This reported case highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS.AbstractFeline restrictive orbital myofibroblastic sarcoma (FROMS) is a rare aggressive tumor in cats. We explored the effectiveness of using toceranib phosphate as postsurgical adjuvant chemotherapy for advanced FROMS in a 7‐year‐old cat. Despite treatment, the cat died 4 months after surgery. This report highlights the need for further studies on the efficacy of toceranib phosphate as adjuvant chemotherapy for FROMS.

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ccr3.7582

Reference35 articles.

1. Retrobulbar tumors in dogs and cats: 25 cases

2. Evaluation of cytology and histopathology for the diagnosis of feline orbital neoplasia: 81 cases (2004‐2019) and review of the literature

3. Diagnostic Features of Feline Restrictive Orbital Myofibroblastic Sarcoma

4. Idiopathic sclerosing orbital pseudotumor in seven cats